Caveolin-3 is the major structural protein of caveolae in muscle cells. Mutations in the CAV3 gene cause different type of muscle disorders mostly characterized by defects in membrane integrity and repair, deregulation in the expression of various muscle proteins and deregulation of several muscle associated signaling pathways.
Introduction
Caveolae are cup-shaped plasma membrane invaginations that were first observed in the 50's by Palade and Yamada on electron micrographs from vascular and gall bladder tissues (Palade, 1953 , Yamada, 1955 . Caveolae present a specific protein signature involving two main families of proteins, caveolins (caveolin-1, -2 and -3), and cavins (cavin-1, -2, -3 and -4) (Aboulaich et al., 2004; Hansen, Howard, and Nichols, 2011; Hill et al., 2008; Morén et al., 2012; Rothberg et al., 1992; Way and Parton, 1995) . Caveolins and cavins are expressed in almost every type of cells, except for caveolin-3 (Cav3) and cavin-4, which are expressed only in smooth and striated muscle cells (Way and Parton, 1995 ; Tagawa et al., 2008) . Similarly to Cav1 in non muscle cells, Cav3 is necessary for the formation of caveolae at the plasma membrane of muscle cells .
Caveolae have long been associated with several important cellular functions including endocytosis, lipid metabolism and cell signaling albeit with several unresolved controversies (Cheng and Nichols, 2016; Lamaze et al., 2017) . More recently, a new function of caveolae was established as mechanosensors that play an essential role in cell mechanoprotection both in vitro and in vivo (Sinha et al., 2011; Lo et al., 2015; Garcia et al., 2017; Y.-W. Lim et al., 2017) . The mechanical function of caveolae is likely to explain their particular abundance at the surface of many specialized cells that undergo chronic mechanical stress during their lifetime such as adipocytes, endothelial and muscle cells. Moreover, mutations or abnormal expression of caveolae components have been associated with lipodystrophy, vascular dysfunction, cancer and muscle disorders (reviewed in Lamaze et al., 2017; Le Lay and Kurzchalia, 2005) . The molecular mechanisms underlying caveolinassociated diseases remain poorly understood.
In this study, we investigated the mechanical role of caveolae in caveolinopathies, a family of muscle diseases involving mutations in the CAV3 gene. Human caveolinopathies can affect both cardiac and skeletal muscle tissues, and encompass five distinct genetic disorders: Rippling Muscle Disease (RMD), Distal Myopathies (DM), HyperCKemia (HCK), Limb-Girdle Muscular Dystrophy 1C (LGMD-1C), and Familial Hypertrophic Cardiomyopathy (HCM) (Gazzerro et al., 2010) ., These disorders share nevertheless common characteristics including mild muscle weakness, high levels of serum creatine kinase, variations in muscle fiber size and an increased number of central nuclei as observed in muscle biopsies (Minetti et al., 1998; Carbone et al., 2000; Betz et al., 2001; Carbone et al., 2000; Tateyama et al., 2002) .
We focused our investigations on two representative human caveolinopathies mutations namely Cav3 P28L and Cav3 R26Q, which are respectively responsible for HCK (Merlini et al., 2002) , and RMD, HCK and LGMD-1C .
These two heterozygous mutations both lead to the abnormal retention of Cav3 in the Golgi complex. The P28L and R26Q Cav3 mutations have so far been associated to deregulations of some signaling pathways Brauers et al., 2010) , defects in membrane repair (Hernandez-Deviez et al., 2008; Cai et al., 2009 ) and defect in the mechanoprotection of the muscle tissue (Lo et al., 2015) .
These studies were conducted either in vivo in transgenic mice or zebrafish or in vitro either in the mouse muscle cell line C2C12 or in fibroblasts overexpressing a mutant form of Cav3, and the mechanical function of caveolae was not extensively explored in this context.
In this study, we investigated whether the phenotype of human myotubes isolated from patients bearing the Cav3 P28L or Cav3 R26Q mutations could be associated with defects in the caveolae-mediated mechanoresponse operating at the plasma membrane. We also tested the new hypothesis that the mechanical flattening of caveolae could be involved in the selective regulation of some signaling pathways important for muscle physiology (Nassoy and Lamaze, 2012) , by studying interleukin-6 (IL6) signaling, a pathway that plays an essential role in muscle tissue homeostasis (Muñoz-Cánoves et al., 2013) .
We show here that the Cav3 P28L and Cav3 R26Q myotubes are unable to assemble bona fide caveolae at the plasma membrane, leading to a loss of membrane tension buffering and membrane integrity under mechanical stress. We also found that the absence of functional caveolae impairs the regulation of the IL6/STAT3 pathway in the mutant myotubes both at rest and under mechanical stress. As a result, the IL6 signaling pathway is chronically hyperactivated and the expression of several of the STAT3 target genes upregulated. Finally, the expression of WT Cav3 in mutant myotubes was sufficient to restore a functional pool of caveolae and to rescue mechanosensing and IL6/STAT3 signaling pathway regulation in these cells.
Results
Drastic decrease of caveolae number at the plasma membrane of Cav3 mutant myotubes.
To address the impact of Cav3 mutations in human muscle disorders, we analyzed wild type (WT), Cav3 P28L and Cav3 R26Q myotubes obtained from immortalized myoblasts which were isolated from healthy or Cav3 mutant patients and differentiated for 4 days. The state of myotube differentiation was validated by the expression level of the differentiation marker MF-20 (myosin II heavy chain) in the three cell lines ( Supplementary Fig. 1a ). We first analyzed the presence and the ultrastructure of caveolae at the plasma membrane of myotubes by electron microscopy. In WT myotubes, we observed many structures corresponding to bona fide caveolae i.e. 60-80 nm cup-shaped invaginations that were directly connected to the plasma membrane or to larger vacuoles of variable size deeper inside the cell known as rosettes, and that could still be connected to the plasma membrane (Fig.   1a ). In contrast, few caveolae if any could be detected at the plasma membrane of mutant myotubes, and no large vacuolar structures were observed.
This drastic decrease of caveolae number led us to investigate the localization of Cav3, since it is required for caveolae assembly at the plasma membrane . Immunoblot analysis showed a reduced expression of mutant Cav3 as compared to WT (Fig. 1b) , with a shifted band for the R26Q mutant corresponding to the Cav3 mutant form, as reported previously . Cav3 immunostaining revealed that WT Cav3 was mainly associated with the plasma membrane of myotubes and also partially localized in the Golgi complex, defined by GM130 staining (Fig. 1c) . On the contrary, in the P28L and R26Q myotubes, Cav3
showed a drastic accumulation in the Golgi complex, as shown by the strong colocalization with GM130, in agreement with published data Brauers et al., 2010) . These data confirm that the Cav3 P28L and R26Q mutations retain Cav3 in the Golgi complex, which results in a drastic reduction of the number of caveolae present at the plasma membrane of the Cav3 mutant myotubes.
After 4 days of differentiation, Cav1 could still be expressed in myotubes and could potentially participate to the formation of caveolae independently from Cav3. We therefore analyzed Cav1 expression in myotubes after 4 days of differentiation and found that Cav1 was indeed expressed to the same level in the three cell lines ( Supplementary Fig. 1b ). We also found that Cav1 colocalized perfectly with Cav3 at the plasma membrane and to a lesser extent at the Golgi complex in WT myotubes whereas it was mainly retained in the Golgi complex in Cav3 P28L and R26Q myotubes ( Supplementary Fig. 1c ). This indicates that Cav1 can form heterooligomers with Cav3, and that the Cav3 P28L and R26Q mutants are dominant on Cav1 localization.
Cav3 P28L and R26Q myotubes display major defects in membrane tension buffering and mechanoprotection under mechanical stress.
To know whether the quasi absence of caveolae at the plasma membrane of mutated myotubes could induce defects in cell mechanoprotection, we first determined if the Cav3 P28L and R26Q myotubes could buffer the increase of membrane tension induced by mechanical stress. We thus applied a 45 mOsm hypo-osmotic shock to myotubes aligned by micropatterning and we measured the apparent membrane tension before and after 5 min of hypo-osmotic shock using membrane nanotube pulling with optical tweezers as described (Sinha et al., 2011) .
While the mutant myotubes showed no significant changes in membrane tension in resting condition (Fig. 2a) , they showed a significant increase of membrane tension (P28L: 63.2% ± 7.47%; R26Q: 93.8% ± 11.2%) under 45 mOsm hypo-osmotic shock compared to WT myotubes (37.9% ± 8.93%) (Fig. 2b) . These results clearly show that the Cav3 P28L and R26Q mutant myotubes have lost the ability to buffer membrane tension variations induced by intense mechanical stress.
We next tested whether the lack of membrane tension buffering could result in insufficient mechanoprotection and increased membrane fragility in mechanically challenged mutant myotubes. We designed an assay to quantify the percent of cells that rupture their membrane under mechanical stress. This membrane bursting assay consists in incubating micropatterned myotubes with calcein-AM, a permeant green fluorescent dye that becomes fluorescent only inside the cell, and with the nucleus specific blue dye DAPI to specifically visualize myotubes by nuclei staining ( Supplementary Fig. 2b ). Live imaging was performed on myotubes subjected for 10 min to a 30 mOsm hypo-osmotic shock in the presence of propidium iodide (PI), a (Fig. 2d) . Importantly, when we apply a milder hypo-osmotic shock (150 mOsm), for which no increase in membrane tension could be measured, the plasma membrane of all three cell lines remained intact after 10 min of shock (Supplementary Fig. 2b and 2c).
In agreement with the absence of caveolae observed at the plasma membrane of the mutant myotubes ( Fig. 1) , when WT myotubes were depleted for Cav3, we measured a percentage of bursted out cells that was similar to mutant myotubes (siCtl: 22.7% ± 1.5%, siCav3: 88.93% ± 1.4%; Fig. 2e and 2f ; Supplementary Fig.   2d ). Likewise, Cav3 depleted myotubes significantly bursted out faster as compared to control myotubes (siCtl: 3.1 min ± 0.2, siCav3: 2.4 min ± 0.1) ( Fig. 2e and 2f ).
Together, our results demonstrate that the Cav3 P28L and R26Q mutant myotubes are unable to provide the mechanoprotection that is required to maintain the integrity of the plasma membrane under mechanical stress and behave similarly to myotubes depleted for Cav3.
Chronic hyperactivation of IL6/STAT3 signaling in Cav3 P28L and R26Q mutant myotubes.
Considering the key role of caveolae and caveolin in intracellular signaling (Lamaze et al., 2017) , we next investigated the possible impact of the loss of functional caveolae on some of the key signaling pathways in the muscle. We focused our analysis on the IL6/STAT3 signaling pathway that has been associated with satellite cells exhaustion and muscle wasting (Bonetto et al., 2011; Price et al., 2014; Tierney et al., 2014) . Furthermore, the IL6 signal transducer glycoprotein gp130, which, together with the IL6 receptor subunit, assemble the IL6 receptor, has been localized in caveolae in a myeloma cell line (Podar et al., 2003) , suggesting a potential regulation of the IL6 signaling pathway by caveolae. IL6 binding to the IL6 receptor is classically followed by the activation of receptor-bound JAK1 and JAK2 kinases, which in turn phosphorylate the signal transducer and activator of transcription 3 (STAT3) that is then translocated as a dimer to the nucleus where it activates the transcription of IL6 sensitive genes (Heinrich et al., 2003 ).
We therefore monitored the level of STAT3 activation i.e. tyrosine phosphorylation STAT3 is a key transcription factor which controls the transcription of many downstream genes whose products mediate the pleiotropic effects of STAT3 in physiological and pathological contexts (Levy and Lee, 2002) . We therefore examined the consequences of IL6/STAT3 chronic activation on gene expression. In the context of muscle diseases, we investigated the transcription of muscle-specific genes as STAT3 was suggested to be involved in their regulation (Bonetto et al., 2011) . We focused our analysis on FBXO32, a gene known to be associated with muscle atrophy, and on the ACTC1, MYH8 and SOCS3 genes that are associated with muscle regeneration. SOCS3 serves also as a positive control, as it is transcribed upon STAT3 activation and its gene product SOCS3 is a major actor in the negative regulation of the pathway (Heinrich et al., 2003) . Using quantitative PCR, we found an increased transcription of SOCS3, MYH8 and ACTC1 genes, and little effect on the FBXO32 gene (SOCS3: WT 1, P28L 2.5 ± 0.58, R26Q: 2.95 ± 1.1;
FBXO32: WT 1, P28L 2.33 ± 1.01, R26Q: 1.65 ± 0.59; MYH8: WT 1, P28L 15,15 ± 4,3, R26Q 5,24 ± 1,6; ACTC1: WT 1, P28L 3,37 ± 1,18, R26Q 12,3 ± 4,56) (Fig. 3g ).
These data strongly suggest that the high level of pSTAT3 found in the Cav3 P28L
and R26Q mutant myotubes is responsible of the deregulation of several genes that could be involved in the muscular pathological phenotype.
Impaired IL6/STAT3 mechanosignaling in Cav3 P28L and R26Q mutant myotubes.
Although caveolae and caveolins have long been associated with signaling (Cheng and Nichols, 2016; Lamaze et al., 2017) , the integration of this function with their role in mechanical stress has not yet been reported. We have proposed the hypothesis that the mechano-dependent cycle of caveolae disassembly and reassembly could be tightly linked to the regulation of some signaling pathways by caveolae (Lamaze et al., 2017; Nassoy and Lamaze, 2012) . We thus analyzed whether the regulation of the IL6/STAT3 pathway by caveolae could depend on mechanical stress. When myotubes were subjected to hypo-osmotic shock and stimulated with IL6, we observed a dramatic decrease of STAT3 activation (approx. 80%) in WT myotubes whereas no significant change was observed in Cav3 P28L and R26Q mutant myotubes (Fig. 4a, b) . We also tested the effect of mechanical stretching on IL6/STAT3 signaling as this is more relevant to the nature of mechanical stress experienced by skeletal muscles during exercise. When we applied a 10% cyclic stretch at 0.5 Hz for 30 min to WT myotubes followed by IL6 stimulation, we also observed a drastic reduction of STAT3 activation, confirming that the IL6/STAT3 pathway is tightly regulated by mechanical cues (Supplementary Fig. 3 ). To know whether the mechanical regulation of IL6 signaling requires the presence of functional caveolae, we also applied an hypo-osmotic shock to WT myotubes depleted of Cav3. While no effect was observed at steady state, we found that STAT3 activation was slightly decreased by mechanical stress (approx. 20%) in WT myotubes when no changes were observed in Cav3 depleted myotubes (Fig. 4c-d .
The poor adhesion of Cav3 P28L and R26Q mutant myotubes on the stretching membrane did not allow to perform cycling stretching. Nevertheless, these results confirm that the IL6 pathway is negatively regulated by mechanical stress in myotubes and that this regulation is lost in the absence of functional caveolae as shown in Cav3 P28L and R26Q mutant myotubes and in WT myotubes depleted for
Cav3. It further confirms that the defects of mechanoprotection and IL6/STAT3
signaling regulation observed in the Cav3 P28L and R26Q mutant myotubes result from the lack of caveolae assembly at their plasma membrane.
Expression of WT Cav3 is sufficient to rescue a normal phenotype in Cav3
P28L myotubes.
Our experiments show that the depletion of Cav3 in WT myotubes reproduces the defects observed in P28L and R26Q myotubes, implying that the absence of Cav3 at the plasma membrane, as a result of its abnormal retention in the Golgi complex, is responsible for the observed phenotype. To validate this hypothesis, we generated stable WT and P28L myoblasts expressing either GFP or Cav3 WT tagged with GFP (Cav3-GFP). Immunofluorescent microscopy confirmed that re-expressed Cav3-GFP was mainly localized at the plasma membrane whereas endogenous Cav3 remained colocalized with the Golgi marker GM130 in Cav3-GFP P28L myotubes ( Fig. 5a and supplementary Fig. 4a ). We next performed electron microscopy to see if Cav3 WT expression would allow to reconstitute a pool of structurally defined caveolae at the plasma membrane of Cav3 P28L myotubes expressing GFP or Cav3 GFP. While the plasma membrane of control GFP myotubes presented very few, often isolated, caveolae structures, Cav3 rescued myotubes presented higher amount of bona fide caveolae, including larger vacuolar structures with connected caveolae i.e. rosettes, as observed above in WT myotubes ( Fig. 5b and 1c ). These observations confirm that the decrease of caveolae numbers in Cav3 P28L myotubes is a direct consequence of the retention of Cav3 P28L in the Golgi complex.
The next question was to know whether the reconstitution of the caveolae reservoir at the plasma membrane of Cav3 P28L myotubes was sufficient to rescue the mechanoprotection and mechanosignaling properties observed in WT myotubes. We therefore monitored the resistance to bursting of P28L GFP and P28L Cav3-GFP myotubes as described above. Notably, Cav3-GFP P28L myotubes showed a dramatic increase in the resistance to bursting under hypo-osmotic shock as compared to P28L GFP myotubes (P28L GFP: 49.01% ± 2.7%; P28L Cav3-GFP:
18.44% ± 2.1%). It also took a significantly longer time for P28L Cav3-GFP myotubes to burst out as compared to P28L GFP myotubes (GFP: 1.63 min ± 0.09; Cav3-GFP: 2.28 min ± 0.21) (Fig. 5c, d ). Finally, we analyzed the regulation of the IL6/STAT3 pathway by monitoring STAT3 phosphorylation and nuclear translocation in P28L GFP and P28L Cav3-GFP myotubes. At steady state, we observed a significant decrease of pSTAT3 activation and nuclear translocation in Cav3-GFP myotubes as compared to GFP myotubes, indicating that the expression of Cav3 was sufficient to reduce the hyperactivation of STAT3 observed at steady state in Cav3 P28L myotubes (P28L GFP: 2.53 ± 0.2, Cav3-GFP: 1.7 ± 0.1) (Fig 5e, f) .
Interestingly, we also found that the expression of Cav3-GFP in WT myotubes led to a decrease of pSTAT3 activation and nuclear translocation at steady state as compared to non transduced WT myotubes ( Supplementary Fig. 4c ). Altogether, these results show that Cav3 expression and localization at the plasma membrane of P28L myotubes was sufficient to rescue the lack of membrane integrity and the hyperactivation of the IL6 pathway described above. We can therefore conclude that the phenotype observed in mutant myotubes is due to a lack of Cav3 and functional caveolae at the plasma membrane.
Discussion
The first CAV3 mutations associated with muscle disorders were described 20 years ago (Minetti et al., 1998) . Since then, a lot of effort has been put in trying to understand how these mutations could alter muscle tissue integrity and cause the observed syndromes. Due to its localization at the plasma membrane of myotubes and at the sarcolemma of muscle fibers, Cav3 has been shown to regulate myoblasts fusion (Bjerregard et al., 2014) and T-tubules organization (Ferruccio Galbiati et al., 2001) . Also, Cav3 interacts with the dystrophin complex (Song et al., 1996) and regulates the trafficking of dysferlin (Hernández-Deviez et al., 2006.) , two important muscle proteins causing severe myopathies when deregulated.
Furthermore, Cav3 is involved in the regulation of different signaling pathways important for muscle function such as calcium homeostasis (Weiss et al., 2008) , the insulin/GLUT4/Akt pathway (Fecchi et al., 2006) or TrkA and EGFR signaling (Brauers et al., 2010) . Finally, we showed a role of Cav3 in membrane tension buffering and mechanoprotection in P28L FHCK human myotubes (Sinha et al., 2011) . Furthermore, a recent in vivo study showed in a model of zebrafish expressing the R26Q mutation, that Cav3 was required for the membrane integrity of muscle tissue (Lo et al., 2015) .
In the present work, we studied human myotubes after differentiation from myoblasts that were isolated and immortalized from healthy patients or patients bearing either the Cav3 P28L or Cav3 R26Q mutation. As Cav3 and caveolae are likely to regulate several functions in myotubes, we chose to focus on two major but poorly explored functions of caveolae that could have an important impact on the integrity of muscle cells and tissue. We first studied mechanoprotection as this function recently described has not been extensively investigated in muscle cells and never in human myotubes. We demonstrate in the present study that the Cav3 P28L and R26Q myotubes show a major defect in mechanoprotection, with less resistance of the plasma membrane to mechanical stress. We show that this defect results from the absence of a functional reservoir of caveolae at the plasma membrane that leads to a lack of membrane tension buffering under mechanical stress.
We then studied the regulation of the IL6/STAT3 signaling pathway in myotubes at rest and under mechanical stress. Indeed, we have proposed that the cycles of caveolae disassembly and reassembly induced by mechanical stress could have an impact on some signaling pathways (Nassoy and Lamaze, 2012) . We tested our hypothesis by investigating the IL6 pathway as it is tightly associated to mechanical stress in muscle cells, with IL6 being secreted mostly during exercise (Ostrowski et al., 1998) . We could show for the first time that the Cav3 mutant myotubes present a major deregulation of the IL6/STAT3 signaling pathway, as this pathway was hyperactivated under resting conditions. This defect translated into increased gene expression of MYH8, SOCS3 and ACTC1, genes that have been associated with muscle regeneration, a process that may be important for the regulation of muscle tissue size. In addition, we show that the IL6 signaling pathway is negatively regulated by mechanical stress in a Cav3 dependent manner, and that this mechano-regulation is lost in mutated myotubes. It is likely that the caveolaedependent mechano-regulation of the IL6/STAT3 pathway allows a negative feedback loop to avoid a chronic activation of the pathway and to adapt it to the mechanical stress that myotubes constantly experience during their lifetime.
Importantly, we also found that Cav3 depleted myotubes phenocopy Cav3 mutant myotubes. Furthermore, the defects in mechanoprotection and IL6 signaling regulation could be, at least partially, rescued in Cav3 P28L myotubes re-expressing the WT form of Cav3 and thereby reassembling a reservoir of functional caveolae at the plasma membrane. In conclusion, our data confirm that the retention of the Cav3 mutated forms in the Golgi complex is responsible for the absence of functional and morphologically defined caveolae at the plasma membrane of mutated myotubes.
This absence leads both to deficient mechanoprotection and impaired mechanoregulation of the IL6/STAT3 signaling pathway, a pathway tightly linked to muscle mass and size. Mechanoprotection and proper regulation of muscle size are two features extremely important for general muscle integrity and it is likely that the alteration of these two processes can be deleterious for muscle tissue integrity, as it is often seen in muscular dystrophic patients.
Methods
Cell lines. P28L and R26Q human myoblasts were immortalized by the platform for immortalization of human cells of the Institute of Myology as described in (Mamchaoui et al., 2011) . Briefly, myoblasts were transduced with lentiviral vectors encoding hTERT and cdk4 and containing puromycin (P28L) or puromycin and neomycin (R26Q) selection markers. Transduced cells were selected with puromycin
(1 µg/ml) for 6 days (P28L) or with puromycin (1 µg/ml) for 6 days and neomycin (1 mg/ml) for 10 days (R26Q). Cells were seeded at clonal density, and individual myogenic clones were isolated. Electron microscopy. Epon embedding was used to preserve the integrity of cell structures. Myotubes were fixed sequentially for 1 hour at room temperature with 1.25% glutaraldehyde in 0.1 M Na-Cacodylate and then overnight at 4°C.
Cells were washed extensively with 0.1 M Na-Cacodylate pH 7.2. Membrane fixation was performed for 1 h at room temperature with 1% OsO4 in 0.1 M Na-Cacodylate pH 7.2. Cells were dehydrated by incubation with aqueous solutions of ethanol at increasing concentrations (50, 70, 90, then 100%, each for 10 min at room temperature). Embedding was finally performed in LX112 resin. Cells were infiltrated with a 1:1 LX112:ethanol solution, washed with LX112, and embedded overnight at 60°C in LX112 resin. Ultrathin 65 nm sections were sliced using a Leica UCT ultramicrotome and mounted on nickel formvar/ carbon-coated grids for observations. Contrast was obtained by incubation of the sections for 10 min in 4% uranyl acetate followed by 1 min in lead citrate.
Electron micrographs were acquired on a Tecnai Spirit electron microscope (FEI,
Eindhoven, The Netherlands) equipped with a 4k CCD camera (EMSIS GmbH,
Münster, Germany)
Micropatterning. 18 mm coverslips were micropatterned as described in ( The membrane tether was held at constant length to measure the static force. For measuring membrane tension changes due to hypo-osmotic shock, a first tether was first pulled at 300 mOsm (iso condition). A second tube was pulled on the same cell 5 minutes after diluting the medium with milliQ water to obtain 45 mOsm. The position of the bead used to compute tether forces was detected from the images using a custom ImageJ macro.
Membrane bursting assay. Line micropatterned myotubes are incubated in 5
µg/mL of calcein-AM (Life techonologies) and 50 µg/mL of DAPI (Sigma-Aldrich) for 15 min at 37°C in the dark. Medium was then switched back with differentiation medium to wash out the excess of calcein-AM. The medium is then switched again with a 30 mOsm hypo-osmotic shock medium obtained after a dilution of 10% medium and 90% H 2 O, supplemented with 2 mg/mL of PI (Sigma). Immediately after medium switching, pictures are taken every minute for 10 min using a videomicroscope (Inverted microscope Nikon Ti-E, Camera: CCD 1392x1040
CoolSnap HQ2, objective: 10x CFI Fluor). 
Statistical analyses
All analyses were performed using GraphPad Prism version 6.0 and 7.0, GraphPad 
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